NCT04611893

Monitoring of NOAC Therapy: Standardizing Reference Intervals

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 308 (actual)
• Sponsor: Chinese University of Hong Kong · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This study is aimed to establish reference intervals of NOAC (dabigatran, apixaban and rivaroxaban) in ethnic Chinese patients.

Detailed description

360 patients who are on dabigatran, apixaban and rivaroxaban based on the above inclusion and exclusion criteria will be recruited. After the informed consent, the patient will be needed for blood taking before and 2 hours after the medication (NOAC). The patient's demographic data and medical history will also be retreived from Central Medical Syetem too.

Conditions

• Ischemic Stroke
• Stroke, Acute
• Stroke Syndrome
• Ischemic

Timeline

• Start date: 2020-11-05
• Primary completion: 2025-06-30
• Completion: 2025-06-30
• First posted: 2020-11-02
• Last updated: 2026-02-24

Locations

1 site across 1 country: Hong Kong